MARKET

ARGX

ARGX

Argenx Se
NASDAQ
851.29
-5.65
-0.66%
After Hours: 850.00 -1.29 -0.15% 16:47 08/14 EDT
OPEN
845.36
PREV CLOSE
856.94
HIGH
852.08
LOW
837.42
VOLUME
278.71K
TURNOVER
--
52 WEEK HIGH
953.58
52 WEEK LOW
631.47
MARKET CAP
53.24B
P/E (TTM)
32.40
1D
5D
1M
3M
1Y
5Y
1D
Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors
TipRanks · 3d ago
Weekly Report: what happened at ARGX last week (0803-0807)?
Weekly Report · 6d ago
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Seeking Alpha · 08/07 21:58
UBS Remains a Hold on arGEN X (0QW0)
TipRanks · 08/07 03:15
argenx Commences $77/Shr Cash Tender Offer Through Subsidiary Avena Merger Sub To Acquire All Outstanding Shares Of Forte Biosciences
Benzinga · 08/06 11:59
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Barchart · 08/06 06:48
J.P. Morgan Keeps Their Buy Rating on arGEN X (0QW0)
TipRanks · 08/06 06:16
Guggenheim Reinstates Buy on argenx, Maintains $1185 Price Target
Benzinga · 08/05 13:42
More
About ARGX
argenx SE, formerly arGEN X BV, is a Netherlands-based biopharmaceutical company. It is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.

Webull offers argenx SE - ADR stock information, including NASDAQ: ARGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARGX stock methods without spending real money on the virtual paper trading platform.